Clinical experience of extended adjuvant treatment in early HER2-positive/HR positive breast cancer with neratinib

Pierre Fabre Pharma Norden AB invites you to a scientific meeting on: Clinical experience of extended adjuvant treatment in early HER2-positive/HR positive breast cancer with neratinib

INTERNET BASED MEETING: TEAMS
11 Mar 2021 (thu)
16.30-17.30 (cet)

Speakers
Professor DIANA LUFTNER
– University Hospital Charité Berlin, Germany

Adjunct Professor MINNA TANNER (Moderator)
– Tampere University Hospital, Finland

REGISTER
Sign up for the meeting by sending an e-mail to: nordics.meds@pierre-fabre.com before March 10, 2021. Write “BC webinar” in the subject line. You will receive the link and instructions on how to join.

For more information and registration details